KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Sales (2018 - 2025)

Historic Return on Sales for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 1.15%.

  • Bionano Genomics' Return on Sales rose 61300.0% to 1.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.34%, marking a year-over-year increase of 27300.0%. This contributed to the annual value of 3.64% for FY2024, which is 28000.0% up from last year.
  • As of Q3 2025, Bionano Genomics' Return on Sales stood at 1.15%, which was up 61300.0% from 1.02% recorded in Q2 2025.
  • Bionano Genomics' Return on Sales' 5-year high stood at 0.48% during Q1 2025, with a 5-year trough of 12.08% in Q3 2023.
  • Its 5-year average for Return on Sales is 4.16%, with a median of 4.41% in 2022.
  • As far as peak fluctuations go, Bionano Genomics' Return on Sales plummeted by -76800bps in 2023, and later soared by 61300bps in 2025.
  • Over the past 5 years, Bionano Genomics' Return on Sales (Quarter) stood at 3.64% in 2021, then decreased by -29bps to 4.71% in 2022, then rose by 13bps to 4.09% in 2023, then skyrocketed by 40bps to 2.47% in 2024, then skyrocketed by 53bps to 1.15% in 2025.
  • Its Return on Sales stands at 1.15% for Q3 2025, versus 1.02% for Q2 2025 and 0.48% for Q1 2025.